Requiring notification to patients that the effects of a medication abortion may be reversible.
Impact
This bill will amend existing Kansas laws under the woman's-right-to-know act, specifically adding requirements for patient notifications around medication abortions. It holds healthcare providers to higher disclosure standards and obligates them to inform patients of potential options to reverse medication abortion effects. The bill also has enforcement measures that impose significant fines and potential criminal penalties for non-compliance, thereby aiming to ensure strict adherence by medical practitioners and facilities.
Summary
House Bill 2439 mandates that medical facilities and pharmacies provide clear notifications to patients undergoing medication abortions. Specifically, the bill focuses on the use of mifepristone, a drug commonly used in medical abortions, outlining that patients must be made aware that it may be possible to reverse the effects if they change their mind before taking the second medication. Facilities are required to display this information prominently and ensure patients have access to resources about the reversal procedure.
Contention
Critics of HB 2439 argue that the bill potentially undermines informed consent by inserting controversial information about the reversibility of medication abortions that may not be grounded in strong scientific consensus. Supporters assert that the bill is a necessary measure to ensure women are fully informed about their options when considering an abortion. The bill's stipulations regarding penalties for non-compliance have also raised concerns over undue pressure on healthcare providers and their ability to operate within the bounds of medical ethics.
A bill for an act relating to medication abortions including required informed consent and the dispensing of abortion-inducing drugs to patients within the state.(Formerly HSB 186.)
A bill for an act relating to medication abortions including required informed consent and the dispensing of abortion-inducing drugs to patients within the state.(See HF 775.)
Requiring that certain written information be provided to patients when a physician or healthcare provider administers or prescribes any medicine or drug for the purpose of inducing an abortion.
A bill for an act relating to abortions including definitions, informed consent, dispensing of abortion-inducing drugs, and other abortion-related provisions. (Formerly HF 2563, HSB 704.) Effective date: 07/01/2026.
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.